Weaver Gaines is currently Chairman and CEO of Evren Technologies, Inc. Previously, he was a director and member of the executive committee of the Florida Research Consortium, a strategic partnership of education, business, and government in Florida formed to enhance the quantity and quality of research and to increase commercialization of research. In 1993, Gaines founded Ixion Biotechnology, a Florida-based, clinical-stage biotechnology company that developed cell-based therapies focused on treatment of metabolic disorders. From April to November 1992, he was a senior advisor on the Washington campaign staff of Bush/Quayle ’92. From 1985 to 1992, he held various senior executive positions with The Mutual Life Insurance Company of New York and its operating subsidiaries. He is also a director of Unified Financial Services, a financial services company, Chairman and General Counsel of Nanotherapeutics, Inc., a clinical stage biopharmaceutical company, and a founding director and past Chairman of the Board of BioFlorida, the Florida biotechnology trade association. Gaines received a BA from Dartmouth College and a JD from the University of Virginia School of Law.